The Irritable Bowel Syndrome (IBS) Market continues to witness steady growth driven by rising gastrointestinal disorders, increasing adoption of IBS-targeted therapeutics, and advancements in diagnostic methods. The irritable bowel syndrome (IBS) market is expected to witness market growth at a rate of 12.90% in the forecast period of 2022 to 2029. With IBS affecting...